Operating Lease, Right-of-Use Asset in USD of aTYR PHARMA INC from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
aTYR PHARMA INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • aTYR PHARMA INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $5.6M, a 4.73% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

aTYR PHARMA INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $5.6M -$278K -4.73% 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $5.68M -$264K -4.44% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $5.75M -$249K -4.15% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $5.82M -$910K -13.5% 31 Dec 2024 10-Q 06 Nov 2025
Q3 2024 $5.88M -$931K -13.7% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $5.94M -$1.18M -16.5% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $6M -$943K -13.6% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $6.73M -$523K -7.21% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $6.81M -$159K -2.28% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $7.12M +$6.29M +761% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $6.94M +$5.89M +561% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $7.25M +$5.98M +472% 31 Dec 2022 10-K 14 Mar 2024
Q3 2022 $6.97M +$5.49M +371% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $827K -$858K -50.9% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $1.05M -$836K -44.3% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $1.27M -$816K -39.2% 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $1.48M -$795K -35% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $1.69M -$776K -31.5% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $1.89M -$757K -28.6% 31 Mar 2021 10-Q 14 May 2021
Q4 2020 $2.08M -$738K -26.2% 31 Dec 2020 10-K 15 Mar 2022
Q3 2020 $2.27M -$720K -24% 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $2.46M -$703K -22.2% 30 Jun 2020 10-Q 13 Aug 2020
Q1 2020 $2.64M -$680K -20.5% 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $2.82M -$679K -19.4% 31 Dec 2019 10-K 24 Mar 2021
Q3 2019 $2.99M 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $3.16M 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $3.32M 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $3.5M 01 Jan 2019 10-K 26 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.